cobas pulse blood glucose monitoring system
FDA 510(k) K252323 · Roche Diagnostics
510(k) numberK252323
Submission
- Device name
- cobas pulse blood glucose monitoring system
- Applicant
- Roche Diagnostics
Indianapolis, IN, US - Received
- July 25, 2025
- Decision date
- June 12, 2026
- Decision
- Substantially Equivalent (SESE)
- Type
- Dual Track 510(k)
- Summary
- 510(k) summary available from FDA
Device classification
- Product code
- PZI – Prescription Use Blood Glucose Meter For Near-Patient Testing
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 862.1345
- Specialty
- Clinical Chemistry
Intended for use in near-patient testing settings for in vitro diagnostic, multiple-patient use for the quantitative determination of glucose throughout all hospital and all professional healthcare settings for use in determining dysglycemia.
Other 510(k)s with product code PZI
| 510(k) | Device | Applicant | Decision |
|---|---|---|---|
| K221349 | XPER Technology PREMIUM Pro Blood Glucose Monitoring SystemPZI · Dual Track | Taidoc Technology Corporation | 11/19/2024SE |
| K220272 | cobas pulse blood glucose monitoring systemPZI · Dual Track | Roche Diagnostics | 04/26/2024SE |
| K232075 | StatStrip Glucose Hospital Meter SystemPZI · Dual Track | Nova Biomedical Corporation | 02/23/2024SE |
| K200788 | Assure Titanium Blood Glucose Monitoring SystemPZI · Dual Track | Arkray, Inc. | 05/23/2022SE |
| K182552 | StatStrip Xpress Glucose Hospital Meter SystemPZI · Dual Track | Nova Biomedical Corporation | 12/13/2018SE |
| K182549 | StatStrip Xpress 2 Glucose Hospital Meter SystemPZI · Dual Track | Nova Biomedical Corporation | 12/13/2018SE |
| K181043 | StatStrip Glucose Hospital Meter SystemPZI · Dual Track | Nova Biomedical Corporation | 07/12/2018SE |
| K163490 | StatStrip Xpress 2 Glucose Hospital Meter SystemPZI · Special | Nova Biomedical Corporation | 01/06/2017SE |
| K161856 | StatStrip Xpress Glucose Hospital Meter SystemPZI · Special | Nova Biomedical Corporation | 11/15/2016SE |
| K152986 | StatStrip Xpress 2 Glucose Hospital Meter SystemPZI · Special | Nova Biomedical Corporation | 01/27/2016SE |
More from Nova Biomedical Corporation
| 510(k) | Device | Decision |
|---|---|---|
| K261686 | Elecsys Phospho-Tau (217P) PlasmaSET · Traditional | 08/19/2026SE |
| K252431 | Elecsys CalcitoninJKR · Traditional | 04/24/2026SE |
| K252280 | Elecsys Anti-SARS-CoV-2 SQVP · Traditional | 04/13/2026SE |
| K260049 | Elecsys Anti-HBc IgMSEI · Traditional | 04/07/2026SE |
| K260048 | Elecsys Anti-HAV IgMLOL · Traditional | 04/07/2026SE |
| K260046 | Elecsys Anti-HBc IISEI · Traditional | 04/07/2026SE |
| K260026 | Tina-quant Cardiac high sensitivity CRP IIINQD · Traditional | 04/02/2026SE |
| K253491 | ISE indirect K for Gen.2; ISE indirect Na for Gen.2; ISE indirect Cl for Gen.2; cobas…CEM · Traditional | 02/12/2026SE |
| K253490 | Glucose HK Gen.3; ONLINE DAT Methadone II; cobas pro integrated solutionsCFR · Traditional | 02/12/2026SE |
| K253839 | Elecsys Anti-SARS-CoV-2QVP · Special | 12/17/2025SE |
Questions and answers
When was cobas pulse blood glucose monitoring system cleared by the FDA?
cobas pulse blood glucose monitoring system (K252323) received a 510(k) decision of Substantially Equivalent on June 12, 2026, 322 days after the submission was received.
What is the product code of K252323?
The FDA product code is PZI – Prescription Use Blood Glucose Meter For Near-Patient Testing, a Class II (moderate risk) device regulated under 21 CFR 862.1345.